Privia Health Group (PRVA) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$20.85
+3.3% on the day
-13.8% over 12 months
52-week range $19.10 – $28.10
Share price and insider trades
PRVA closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$22.2M
Insiders buying0
Insiders selling4
Privia Health Group insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $22.2M of PRVA stock on the open market.
Get emailed when insiders cluster-buy stocks like PRVA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PRVA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $6.6M | 7 |
| Q2 2026 | — | 0 | $9.2M | 12 |
| Q1 2026 | — | 0 | $5.5M | 19 |
| Q4 2025 | — | 0 | $939K | 2 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Privia Health Group, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $22.2M. 28 of 40 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jul 13SEC | David MountcastleCFO | Sell Plan | 21,275164,853 held (−11%) | $27.67 | $589K | -24.6% | — |
| Jul 9SEC | David MountcastleCFO | Sell Plan | 600186,128 held (−0%) | $27.57 | $17K | -24.4% | — |
| Jul 7SEC | Matthew Shawn MorrisDirector | Sell Plan | 59,03776,651 held (−44%) | $27.33 | $1.6M | -23.7% | — |
| Jul 7SEC | Matthew Shawn MorrisDirector | Sell Plan | 53,72268,188 held (−44%) | $27.24 | $1.5M | -23.5% | — |
| Jul 7SEC | David MountcastleCFO | Sell Plan | 24,734186,728 held (−12%) | $27.50 | $680K | -24.2% | — |
| Jul 2SEC | Matthew Shawn MorrisDirector | Sell Plan | 52,82376,651 held (−41%) | $25.72 | $1.4M | -18.9% | — |
| Jul 2SEC | Matthew Shawn MorrisDirector | Sell Plan | 45,634113,692 held (−29%) | $26.52 | $1.2M | -21.4% | — |
| Jul 2SEC | Matthew Shawn MorrisDirector | Sell Plan | 37,04176,651 held (−33%) | $26.93 | $998K | -22.6% | — |
| Jun 30SEC | Matthew Shawn MorrisDirector | Sell Plan | 88,11076,651 held (−53%) | $25.33 | $2.2M | -17.7% | — |
| Jun 30SEC | Matthew Shawn MorrisDirector | Sell Plan | 63,21276,651 held (−45%) | $25.33 | $1.6M | -17.7% | — |
| Jun 30SEC | David MountcastleCFO | Sell Plan | 17,196211,462 held (−8%) | $25.18 | $433K | -17.2% | — |
| May 13SEC | Parth MehrotraCEO | Sell Plan | 105,439450,004 held (−19%) | $22.55 | $2.4M | -7.5% | — |
| May 13SEC | Parth MehrotraCEO | Sell Plan | 15,647434,357 held (−3%) | $22.64 | $354K | -7.9% | — |
| May 13SEC | David MountcastleCFO | Sell | 3,385211,462 held (−2%) | $22.60 | $77K | -7.7% | — |
| May 5SEC | Matthew Shawn MorrisDirector | Sell Plan | 17,09668,188 held (−20%) | $24.99 | $427K | -16.6% | — |
| May 5SEC | David MountcastleCFO | Sell Plan | 7,179214,847 held (−3%) | $25.03 | $180K | -16.7% | — |
| May 5SEC | David MountcastleCFO | Sell Plan | 1,206214,847 held (−1%) | $25.00 | $30K | -16.6% | — |
| May 5SEC | Matthew Shawn MorrisDirector | Sell Plan | 1,01768,188 held (−1%) | $24.96 | $25K | -16.5% | — |
| Apr 6SEC | David MountcastleCFO | Sell | 5,566214,847 held (−3%) | $20.85 | $116K | +0.0% | — |
| Mar 18SEC | Parth MehrotraCEO | Sell | 26,509555,443 held (−5%) | $22.11 | $586K | -5.7% | — |
| Mar 18SEC | David MountcastleCFO | Sell | 6,391220,413 held (−3%) | $22.11 | $141K | -5.7% | — |
| Mar 16SEC | Parth MehrotraCEO | Sell | 26,763609,181 held (−4%) | $21.90 | $586K | -4.8% | — |
| Mar 16SEC | Parth MehrotraCEO | Sell | 27,229581,952 held (−4%) | $21.52 | $586K | -3.1% | — |
| Mar 16SEC | David MountcastleCFO | Sell | 6,453233,369 held (−3%) | $21.90 | $141K | -4.8% | — |
| Mar 16SEC | David MountcastleCFO | Sell | 6,565226,804 held (−3%) | $21.52 | $141K | -3.1% | — |
| Mar 12SEC | Parth MehrotraCEO | Sell Plan | 21,097322,698 held (−6%) | $22.71 | $479K | -8.2% | — |
| Mar 10SEC | Parth MehrotraCEO | Sell Plan | 21,915363,879 held (−6%) | $22.84 | $501K | -8.7% | — |
| Mar 10SEC | Parth MehrotraCEO | Sell Plan | 21,440385,794 held (−5%) | $23.15 | $496K | -9.9% | — |
| Mar 10SEC | Parth MehrotraCEO | Sell Plan | 18,865343,795 held (−5%) | $22.84 | $431K | -8.7% | — |
| Mar 10SEC | David MountcastleCFO | Sell | 5,829161,903 held (−3%) | $22.84 | $133K | -8.7% | — |
| Mar 10SEC | David MountcastleCFO | Sell | 5,177167,732 held (−3%) | $23.15 | $120K | -9.9% | — |
| Mar 10SEC | Edward C FargisGeneral Counsel | Sell | 4,94983,711 held (−6%) | $22.84 | $113K | -8.7% | — |
| Mar 10SEC | Edward C FargisGeneral Counsel | Sell | 4,39488,660 held (−5%) | $23.15 | $102K | -9.9% | — |
| Mar 10SEC | Parth MehrotraCEO | Sell Plan | 1,219362,660 held (−0%) | $23.37 | $28K | -10.8% | — |
| Mar 2SEC | Matthew Shawn MorrisDirector | Sell Plan | 16,55068,188 held (−20%) | $25.00 | $414K | -16.6% | — |
| Mar 2SEC | Matthew Shawn MorrisDirector | Sell Plan | 7,78868,188 held (−10%) | $24.99 | $195K | -16.6% | — |
| Mar 2SEC | David MountcastleCFO | Sell Plan | 7,697172,909 held (−4%) | $25.05 | $193K | -16.8% | — |
| Mar 2SEC | David MountcastleCFO | Sell Plan | 5,361172,909 held (−3%) | $25.00 | $134K | -16.6% | — |
| Dec 16SEC | David MountcastleCFO | Sell Plan | 23,887172,909 held (−12%) | $25.03 | $598K | -16.7% | — |
| Dec 16SEC | Matthew Shawn MorrisDirector | Sell Plan | 13,64768,188 held (−17%) | $25.01 | $341K | -16.6% | — |
Insiders at Privia Health Group, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Matthew Shawn MorrisDirector | — | $11.9M | Jul 7, 2026 | — |
| Parth MehrotraCEO | — | $6.4M | May 13, 2026 | — |
| David MountcastleCFO | — | $3.7M | Jul 13, 2026 | — |
| Edward C FargisGeneral Counsel | — | $215K | Mar 10, 2026 | — |
PRVA stock: common questions
Are Privia Health Group, Inc. insiders buying PRVA stock?
In the past 12 months, 0 insiders reported open-market purchases of PRVA worth $0.
Are Privia Health Group, Inc. insiders selling PRVA stock?
4 insiders reported sales worth $22.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PRVA's 52-week range?
Over the past year PRVA has traded between $19.10 and $28.10. It last closed at $20.85 on Oct 9, 2026.